Trigyn Technologies Secures Approval for 4.5 Lakh Equity Shares Under ESOP 2025 Aug 12, 2025
Trigyn Technologies Limited (TTL) received approval from NSE and BSE to list 4,50,000 equity shares under its Employee Stock Option Plan 2025. The approval is subject to compliance with SEBI regulations and other conditions. However, TTL's Q1 FY2025-26 financial results show a decline, with consolidated revenue dropping to ₹22,450.00 lakhs and a net loss of ₹460.86 lakhs. The company also faces challenges including arbitration proceedings with NMSCDCL and a GST department notice for ₹9.08 crores. On the positive side, TTL approved new roles for an executive and received approval to incorporate a subsidiary in Dubai.
Trigyn Technologies Reports Q1 Loss of Rs 460.86 Crore, Appoints New Executive Vice Chair Aug 11, 2025
Trigyn Technologies Appoints Former Birlasoft Executive Vikram Chandna as New CEO Apr 28, 2025